Barry W Feig
Overview
Explore the profile of Barry W Feig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
181
Citations
5199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roland C, Nassif Haddad E, Keung E, Wang W, Lazar A, Lin H, et al.
Nat Cancer
. 2024 Feb;
5(4):625-641.
PMID: 38351182
Based on the demonstrated clinical activity of immune-checkpoint blockade (ICB) in advanced dedifferentiated liposarcoma (DDLPS) and undifferentiated pleomorphic sarcoma (UPS), we conducted a randomized, non-comparative phase 2 trial ( NCT03307616...
2.
Witt R, Voss R, Chiang Y, Nguyen S, Scally C, Lin P, et al.
Ann Surg Oncol
. 2023 Feb;
30(6):3668-3676.
PMID: 36723723
Background: Regional lymph node metastasis in extremity and trunk soft tissue sarcoma (ETSTS) is rare with no standardized management. We sought to determine management patterns for regional lymph node metastasis...
3.
Erstad D, Chiang Y, Witt R, Cope B, Nassif E, Scally C, et al.
Ann Surg Oncol
. 2022 Sep;
30(2):926-940.
PMID: 36115928
Introduction: EORTC-62092 (STRASS) was a phase 3, randomized study that compared surgery alone versus surgery plus neoadjuvant radiotherapy (RT) for retroperitoneal sarcomas. RT was not associated with improved abdominal recurrence-free...
4.
Traweek R, Martin A, Rajkot N, Guadagnolo B, Bishop A, Lazar A, et al.
Ann Surg Oncol
. 2022 Sep;
30(1):480-489.
PMID: 36085392
Background: Patients with unplanned excision (UPE) of trunk and extremity soft tissue sarcoma (STS) present a significant management challenge for sarcoma specialists. Oncologic re-resection has been considered standard practice after...
5.
Witt R, Cope B, Erstad D, Chiang Y, Nassif E, Scally C, et al.
Ann Surg Oncol
. 2022 May;
29(11):7092-7100.
PMID: 35501583
Background: Lymph node metastases (LNMs) are rare in patients with soft tissue sarcoma (STS), and there is limited evidence to guide clinical management. We describe our experience with sentinel lymph...
6.
Voss R, Callegaro D, Chiang Y, Fiore M, Miceli R, Keung E, et al.
Ann Surg Oncol
. 2022 Feb;
PMID: 35224688
Background: Sarculator is an online validated nomogram that predicts overall survival of patients with resected, primary extremity sarcomas. However, its ability to accurately predict outcomes in US patients with sarcoma...
7.
Nassif E, Cope B, Traweek R, Witt R, Erstad D, Scally C, et al.
Int J Cancer
. 2022 Feb;
150(12):2012-2024.
PMID: 35128664
Palbociclib has been evaluated in early phase trials for well-differentiated liposarcoma (WDLPS) and dedifferentiated liposarcoma (DDLPS) patients, with reported median progression-free survival (PFS) of 18 weeks. Here, we report on...
8.
Kochat V, Raman A, Landers S, Tang M, Schulz J, Terranova C, et al.
Acta Neuropathol
. 2021 Jul;
142(3):565-590.
PMID: 34283254
Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that frequently harbor genetic alterations in polycomb repressor complex 2 (PRC2) components-SUZ12 and EED. Here, we show that PRC2 loss...
9.
Voss R, Massarweh N, Chiang Y, Somaiah N, Feig B, Roland C
Ann Surg Oncol
. 2021 May;
28(13):9159-9168.
PMID: 34046772
Background: Imatinib decreases recurrence risk and improves overall survival (OS) in localized gastrointestinal stromal tumors (GISTs); however, the extent to which patients receive appropriate treatment in the US has not...
10.
Landry J, Schertz K, Chiang Y, Bhalla A, Yi M, Keung E, et al.
JAMA Netw Open
. 2021 Mar;
4(3):e210945.
PMID: 33734413
Importance: Neurofibromatosis type 1 (NF1) is a complex genetic disorder that is associated with not only neurofibromas, but also an increased susceptibility to other neoplasms. Objective: To evaluate the prevalence...